This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$181.8M
Filings
112
Firms Hired
1
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on legislative and administrative action related to Medicare inpatient reimbursement for cell and gene therapies. H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 7871, Medicaid VBPs for Patients Act (MVP Act). S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 1492
RESTORE Patent Rights Act of 2025
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 1574
ESA Amendments Act of 2025
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to climate change, including sustainable agriculture. Monitor and engage on legislative and administrative action related to FIFRA Regulations, including voluntary carbon markets. Monitor and engage on legislative and administrative action related to the Endangered Species Act. H.R. 1897, ESA Amendments Act of 2025.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 1897
ESA Amendments Act of 2025
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to phosphate mining operations and permits. Monitor and engage on legislative and administrative action related to the Endangered Species Act. Monitor and engage on legislative and administrative action related to the Fairness and Certainty in Reclamation Act (no bill number yet). H.R. 1897, ESA Amendments Act of 2025.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 1897
Patent Eligibility Restoration Act of 2025
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 3152
PREVAIL Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 3160
ETHIC Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 3269
Safe Step Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 5509
Support and Defend Our Military Personnel and Their Families Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 6118
Dietary Supplement Regulatory Uniformity Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 7366
Farm, Food, and National Security Act of 2026
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 7567
No Immunity for Glyphosate Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 7601
Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on legislative and administrative action related to Medicare inpatient reimbursement for cell and gene therapies. H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 7871, Medicaid VBPs for Patients Act (MVP Act). S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 7871
Dietary Supplements Access Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 8933
Advancing Menopause Care and Mid-Life Women’s Health Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9090
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to FY2027 Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative and administrative action related to FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. H.R. 9171, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027. H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9171
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to FY2027 Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative and administrative action related to FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. H.R. 9171, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027. H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9260
People Over Poison Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9528
Fair Seeds for Farmers Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9681
Fair Seeds for Farmers Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9681
Americans vs. Poisonous Pesticides Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.
Client expense: $1,710,000 · Firm income: —
Matched citations: H.R. 9807
Patent Eligibility Restoration Act of 2025
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: S. 1546
PREVAIL Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: S. 1553
Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: S. 2276
Safe Step Act
2026 · third_quarter · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.
Client expense: $1,710,000 · Firm income: —
Matched citations: S. 2903
Source: Senate LDA